The Tailored Adherence Incentives for Childhood Asthma Medications (TAICAM) Trial

NACompletedINTERVENTIONAL
Enrollment

125

Participants

Timeline

Start Date

September 1, 2019

Primary Completion Date

July 17, 2022

Study Completion Date

July 17, 2022

Conditions
Medication AdherenceAsthma in Children
Interventions
OTHER

Nominal Financial Incentives

The nominal financial incentives will consist of fixed-ratio incentives for each inhaled corticosteroids (ICS) actuation (25 cents for children on 4 daily ICS doses and 50 cents for children on 2 daily doses), with a maximum of $1 per day.

OTHER

Daily Adherence Reminders/Adherence Performance Feedback

Study participants will receive automated daily text message or push notification reminders and automated weekly feedback summarizing their adherence performance through Way to Health, a mobile health, electronic monitoring platform.

Trial Locations (1)

19104

Children's Hospital of Philadelphia, Philadelphia

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Children's Hospital of Philadelphia

OTHER

NCT03907410 - The Tailored Adherence Incentives for Childhood Asthma Medications (TAICAM) Trial | Biotech Hunter | Biotech Hunter